{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:42:08Z","timestamp":1793173328674,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.ymgme.2009.08.002","type":"journal-article","created":{"date-parts":[[2009,8,23]],"date-time":"2009-08-23T08:23:48Z","timestamp":1251015828000},"page":"62-71","source":"Crossref","is-referenced-by-count":64,"title":["Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation"],"prefix":"10.1016","volume":"99","author":[{"given":"Dan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trenton R.","family":"Schoeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne A.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Bedwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M.","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2009.08.002_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10545-008-1040-5","article-title":"Pathogenic cascades in lysosomal disease \u2013 Why so complex?","volume":"32","author":"Walkley","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2009.08.002_bib2","unstructured":"E.F. Neufeld, J. Muenzer, The Mucopolysaccharidoses, The Online Metabolic & Molecular Bases of Inherited Disease (www.ommbid.com), The McGraw-Hill Companies, 2001, pp. 3421\u20133452."},{"key":"10.1016\/j.ymgme.2009.08.002_bib3","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymgme.2009.08.002_bib4","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.bbamcr.2008.12.001","article-title":"Lysosomal disorders: from storage to cellular damage","volume":"1793","author":"Ballabio","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymgme.2009.08.002_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1006\/mgme.1999.2860","article-title":"Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats","volume":"67","author":"He","year":"1999","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.08.002_bib6","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1203\/00006450-197911000-00018","article-title":"Alpha-l-iduronidase deficiency in a cat: a model of mucopolysaccharidosis I","volume":"13","author":"Haskins","year":"1979","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2009.08.002_bib7","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1073\/pnas.80.19.6091","article-title":"A canine model of human alpha-l-iduronidase deficiency","volume":"80","author":"Spellacy","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2009.08.002_bib8","first-page":"244","article-title":"Canine alpha-l-iduronidase deficiency. A model of mucopolysaccharidosis I","volume":"109","author":"Shull","year":"1982","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2009.08.002_bib9","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0888-7543(05)80182-X","article-title":"Architecture of the canine IDUA gene and mutation underlying canine mucopolysaccharidosis I","volume":"14","author":"Menon","year":"1992","journal-title":"Genomics"},{"key":"10.1016\/j.ymgme.2009.08.002_bib10","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1073\/pnas.252784899","article-title":"Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB","volume":"100","author":"Ohmi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2009.08.002_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/6.4.503","article-title":"Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-l-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2009.08.002_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1096-7192(03)00116-1","article-title":"Treatment of the mouse model of mucopolysaccharidosis I with retrovirally transduced bone marrow","volume":"79","author":"Zheng","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.08.002_bib13","first-page":"487","article-title":"Morphologic and biochemical studies of canine mucopolysaccharidosis I","volume":"114","author":"Shull","year":"1984","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2009.08.002_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.brainresbull.2007.07.018","article-title":"Characterization of an immunodeficient mouse model of mucopolysaccharidosis type I suitable for preclinical testing of human stem cell and gene therapy","volume":"74","author":"Garcia-Rivera","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ymgme.2009.08.002_bib15","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ymthe.2004.03.011","article-title":"Correction of metabolic, craniofacial, and neurologic abnormalities in MPS I mice treated at birth with adeno-associated virus vector transducing the human alpha-l-iduronidase gene","volume":"9","author":"Hartung","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2009.08.002_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1399-0004.1998.tb02745.x","article-title":"Murine MPS I: insights into the pathogenesis of Hurler syndrome","volume":"53","author":"Russell","year":"1998","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2009.08.002_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/ana.20150","article-title":"Prevention of neuropathology in the mouse model of Hurler syndrome","volume":"56","author":"Desmaris","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2009.08.002_bib18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00001665-200405000-00009","article-title":"Craniofacial abnormalities in a murine knock-out model of mucopolysaccharidosis I H: a computed tomography and anatomic study","volume":"15","author":"Graupman","year":"2004","journal-title":"J. Craniofac. Surg."},{"key":"10.1016\/j.ymgme.2009.08.002_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymthe.2004.08.027","article-title":"Liver-directed neonatal gene therapy prevents cardiac, bone, ear, and eye disease in mucopolysaccharidosis I mice","volume":"11","author":"Liu","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2009.08.002_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.brainres.2007.10.036","article-title":"Progression of multiple behavioral deficits with various ages of onset in a murine model of Hurler syndrome","volume":"1188","author":"Pan","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2009.08.002_bib21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brainres.2006.01.008","article-title":"Long-term memory for aversive training is impaired in Idua(\u2212\/\u2212) mice, a genetic model of mucopolysaccharidosis type I","volume":"1076","author":"Reolon","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.ymgme.2009.08.002_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1203\/01.pdr.0000190579.24054.39","article-title":"Cardiac functional and histopathologic findings in humans and mice with mucopolysaccharidosis type I: implications for assessment of therapeutic interventions in hurler syndrome","volume":"59","author":"Braunlin","year":"2006","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2009.08.002_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ymgme.2005.05.003","article-title":"Cardiac manifestations in the mouse model of mucopolysaccharidosis I","volume":"86","author":"Jordan","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.08.002_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/bmme.1996.0044","article-title":"Long-term and high-dose trials of enzyme replacement therapy in the canine model of mucopolysaccharidosis I","volume":"58","author":"Kakkis","year":"1996","journal-title":"Biochem. Mol. Med."},{"key":"10.1016\/j.ymgme.2009.08.002_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0009-8981(79)90121-9","article-title":"A fluorometric assay using 4-methylumbelliferyl alpha-l-iduronide for the estimation of alpha-l-iduronidase activity and the detection of Hurler and Scheie syndromes","volume":"92","author":"Hopwood","year":"1979","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2009.08.002_bib26","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1172\/JCI114010","article-title":"Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency","volume":"83","author":"Birkenmeier","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2009.08.002_bib27","article-title":"Hexosaminidase assays","author":"Wendeler","year":"2008","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ymgme.2009.08.002_bib28","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/clinchem\/35.3.374","article-title":"Diagnostic test for mucopolysaccharidosis. I. Direct method for quantifying excessive urinary glycosaminoglycan excretion","volume":"35","author":"Whitley","year":"1989","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2009.08.002_bib29","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/clinchem\/38.6.803","article-title":"Measuring urinary glycosaminoglycans in the presence of protein: an improved screening procedure for mucopolysaccharidoses based on dimethylmethylene blue","volume":"38","author":"de Jong","year":"1992","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2009.08.002_bib30","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ymthe.2004.10.006","article-title":"Neonatal gene therapy of MPS I mice by intravenous injection of a lentiviral vector","volume":"11","author":"Kobayashi","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2009.08.002_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.ymgme.2009.08.002_bib32","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/humu.1380060403","article-title":"Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications","volume":"6","author":"Scott","year":"1995","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2009.08.002_bib33","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1101\/gad.7.9.1737","article-title":"MRNA destabilization triggered by premature translational termination depends on at least three cis-acting sequence elements and one trans-acting factor","volume":"7","author":"Peltz","year":"1993","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymgme.2009.08.002_bib34","first-page":"999","article-title":"Evidence for degradation of mRNA encoding alpha-l-iduronidase in Hurler fibroblasts with premature termination alleles","volume":"40","author":"Menon","year":"1994","journal-title":"Cell. Mol. Biol. (Noisy-le-Grand)"},{"key":"10.1016\/j.ymgme.2009.08.002_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ymgme.2006.08.001","article-title":"Effect of neonatal administration of a retroviral vector expressing alpha-l-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice","volume":"90","author":"Chung","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2009.08.002_bib36","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/sj.mt.6300112","article-title":"Improvements in mucopolysaccharidosis I mice after adult retroviral vector-mediated gene therapy with immunomodulation","volume":"15","author":"Ma","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2009.08.002_bib37","doi-asserted-by":"crossref","first-page":"35765","DOI":"10.1074\/jbc.M705124200","article-title":"Lysosomal dysfunction results in altered energy balance","volume":"282","author":"Woloszynek","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2009.08.002_bib38","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1172\/JCI200319777","article-title":"Targeted gene repair \u2013 in the arena","volume":"112","author":"Kmiec","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2009.08.002_bib39","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tig.2008.08.010","article-title":"Introducing sense into nonsense in treatments of human genetic diseases","volume":"24","author":"Linde","year":"2008","journal-title":"Trends Genet."},{"key":"10.1016\/j.ymgme.2009.08.002_bib40","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/157016005774913149","article-title":"Pharmacological suppression of premature stop mutations that cause genetic diseases","volume":"3","author":"Keeling","year":"2005","journal-title":"Curr. Pharmacogenomics"},{"key":"10.1016\/j.ymgme.2009.08.002_bib41","series-title":"Nonsense-Mediated mRNA Decay","first-page":"121","article-title":"Therapies of nonsense-associated diseases","author":"Keeling","year":"2006"},{"key":"10.1016\/j.ymgme.2009.08.002_bib42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/hmg\/10.3.291","article-title":"Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-l-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation","volume":"10","author":"Keeling","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2009.08.002_bib43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00109-001-0317-z","article-title":"Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system","volume":"80","author":"Keeling","year":"2002","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ymgme.2009.08.002_bib44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molmed.2006.06.001","article-title":"Stop-codon read-through for patients affected by a lysosomal storage disorder","volume":"12","author":"Brooks","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ymgme.2009.08.002_bib45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","article-title":"The clinical outcome of Hurler syndrome after stem cell transplantation","volume":"14","author":"Aldenhoven","year":"2008","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"Suppl. 94","key":"10.1016\/j.ymgme.2009.08.002_bib46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/08035320510028120","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type I","volume":"1","author":"Miebach","year":"2005","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2009.08.002_bib47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1128\/AAC.24.2.147","article-title":"Effect of osmotic blood-brain barrier disruption on gentamicin penetration into the cerebrospinal fluid and brains of normal rabbits","volume":"24","author":"Strausbaugh","year":"1983","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymgme.2009.08.002_bib48","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1128\/AAC.32.7.1034","article-title":"Gentamicin penetration into cerebrospinal fluid in experimental Haemophilus influenzae meningitis","volume":"32","author":"Smith","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ymgme.2009.08.002_bib49","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/bmj.2.5551.539","article-title":"Intrathecal gentamicin in treatment of ventriculitis in children","volume":"2","author":"Newman","year":"1967","journal-title":"Br. Med. J."},{"issue":"Suppl. 124","key":"10.1016\/j.ymgme.2009.08.002_bib50","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/infdis\/124.Supplement_1.S214","article-title":"Pharmacologic evaluation of gentamicin in newborn infants","volume":"124","author":"McCracken","year":"1971","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymgme.2009.08.002_bib51","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/106002809202600416","article-title":"Effectiveness of a gentamicin dosing protocol based on postconceptional age: comparison to published neonatal guidelines","volume":"26","author":"Lopez-Samblas","year":"1992","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ymgme.2009.08.002_bib52","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/j.1875-9114.1995.tb02893.x","article-title":"The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients","volume":"15","author":"Ho","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ymgme.2009.08.002_bib53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.biochem.76.050106.093909","article-title":"The nonsense-mediated decay RNA surveillance pathway","volume":"76","author":"Chang","year":"2007","journal-title":"Ann. Rev. Biochem."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719209002431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719209002431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,16]],"date-time":"2024-03-16T00:48:33Z","timestamp":1710550113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719209002431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1096719209002431"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2009.08.002","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}